The list price can be $1,000 monthly, although costs vary among the specific drugs
A study published in Diabetes, Obesity and Metabolism found that patients taking GLP-1 medications had a lower risk of developing Alzheimers disease and other dementias
For many people, especially those dealing with stubborn weight gain, this signal can feel quieter than it should
Retatrutide is still in clinical trials and is expected to be available in 2026 or later
GLP-1 medications can be beneficial for managing Type 2 diabetes and promoting weight loss in some people, but they may not be suitable for everyone
However, interpreting the direct impact of gut-derived neurotransmitters on CNS function requires caution, as most peripheral neurotransmitters cannot freely cross the BBB under homeostatic conditions [187]